Glenmark Pharma Q2 results: Net profit rises 17% to Rs 275 cr

By Nick J Adam On Nov 13, 2021

New Delhi: Drug firm Glenmark Pharmaceuticals on Friday reported a 17.44 per cent jump in its consolidated net profit to Rs 274.80 crore for the quarter ended September 30, 2021. The company had posted a net profit of Rs 233.99 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a regulatory filing.

Its consolidated revenue from operations during July-September 2021 stood at Rs 3,147.44 crore. It was Rs 2,952.47 crore for the same period a year ago, it added.

Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said, “We delivered yet another quarter of consistent performance, both in revenue growth and profitability. We have continued to perform well in our core therapy areas and launched differentiated products.”

Shares of Glenmark Pharmaceuticals on Friday closed at Rs 523.65 per scrip on the BSE, up 1.68 per cent from its previous close.

Stay connected with us on social media platform for instant update click here to join our T witter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Education News Click Here

For the latest news and updates, follow us on Google News.

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.